Genomize in Scientific Articles

You are here:
Orange document icon with pencil
The Clinical and Molecular Spectrum of Patients With X-Linked Intellectual Disability and Novel Variations in Different Genes

Gürsoy et al. (2025) identified a genetic cause in 29% of children with unexplained intellectual disability through Genomize-SEQ targeted panel analysis — including three novel variants, one linked to a brain malformation never before associated with that gene.

Orange document icon with pencil
Phenotypic variability in cases with CACNA1A mutation

Through Genomize-SEQ variant analysis, Bozkaya-Yilmaz et al. (2025) showed that CACNA1A mutations in 31 children can cause a wide range of neurological symptoms — from epilepsy and developmental delay to movement problems — even within the same family.

Orange document icon with pencil
Apparent efficacy of NMDAR antagonist use as a targeted therapy for status epilepticus in an infant with ATP1A2-related developmental epileptic encephalopathy

Tekin Orgun et al. (2025) used Genomize-SEQ to identify a rare ATP1A2 gene mutation in an infant with life-threatening, treatment-resistant seizures, showing that memantine — a drug that blocks overactivated brain receptors — stopped the seizures entirely when all standard therapies had failed.

Orange document icon with pencil
Genetic insights into non-obstructive azoospermia: Implications for diagnosis and TESE outcomes

Through Genomize-SEQ exome analysis, Sharif et al. (2025) found genetic mutations in 42% of men with unexplained infertility, revealing that sperm cell division gene mutations reliably predict failed surgical sperm retrieval — sparing patients from unnecessary procedures.

Orange document icon with pencil
Revealing Molecular Diagnosis With Whole Exome Sequencing in Patients With Inherited Retinal Disorders

Yavas et al. (2025) used Genomize-SEQ to analyze whole-exome sequencing data from 50 Turkish patients with inherited eye diseases, identifying the genetic cause in 58% of cases — including six previously unknown variants — and pinpointing a likely common founder mutation in the ABCA4 gene within the Turkish population.

Orange document icon with pencil
Status of IKZF1 Deletions in Diagnose and Relapsed Pediatric B-ALL Patients

Erbilgin et al. (2026) used Genomize-SEQ to analyze targeted sequencing data from pediatric leukemia patients, finding that a key gene deletion (IKZF1) became more frequent at relapse — pointing to its role in treatment resistance rather than early disease prediction.

Orange document icon with pencil
Clinical features and molecular genetics of patients with RASopathies: expanding the phenotype with rare genes and novel variants

Yılmaz Uzman et al. (2025) used Genomize-SEQ to analyze targeted gene panel data from 149 children with suspected RASopathies, identifying disease-causing variants in over a quarter of patients and uncovering three new genetic variants — including rare clinical features never before described in these conditions.

Orange document icon with pencil
Clinical, electrophysiological, and genetic analysis of a family with two rare neuromuscular disorders: congenital myasthenic syndrome and hereditary polyneuropathy

Tezen et al. (2024) used Genomize-SEQ to analyze whole exome sequencing data from a multi-generational family, discovering that two rare nerve disorders, a neuromuscular junction defect and a hereditary neuropathy, were caused by separate gene mutations co-existing in the same family due to a history of consanguineous marriages.

Become a part of Genomize community!